fashion -WSS

fashion

author：knowledge 2025-10-02 20:49:01 - browse：18

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Pfizer is about to make a big push in cancer. Will investors listen?

WSS

Questions loom on AstraZeneca cancer drug as safety concerns ebb

CZI to create biohub to build anti

Why a market frenzy over new weight loss drugs defies logic

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

FDA clears Verve to begin U.S. study of gene

Color Health wants to make cancer screenings convenient

knowledge

fashion

explore

Medical records are filled with copy

STAT Summit: Ending the crisis of Black deaths in the U.S.

Medical records are filled with copy

STAT Summit: Meghan O’Rourke on making chronic illness visible

Medical leaders decry Supreme Court decision on affirmative action

Readout LOUD podcast: Live from the 2023 STAT Summit

Sports medicine is finally prioritizing gender equality

FDA clears Verve to begin U.S. study of gene

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

focus

Children’s Hospital revives plan for pedestrian bridge

5 ways to address the shortage of health care workers

Study fuels hope CAR

STAT Summit: The economic case for universal basic health care

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Roche acquires Telavant from Roivant, adding experimental IBD treatment

explore

focus

entertainment

focus